基于前瞻性人群分析的同患嗜酸性食管炎与炎症性肠病的流行病学及临床意义
该前瞻性队列分析利用Truven MarketScan数据库(2009-2016)估算嗜酸性食管炎(EoO)与炎症性肠病(IBD)相互并发的发病率和患病率,并评估并发诊断对并发症风险的影响。结果显示IBD患者发生EoO的风险增高,反之亦然;并发诊断可能改变IBD相关和EoO相关并发症的风险。
要点
- 在134 013 536名个体中,EoO、克罗恩病(CD)和溃疡性结肠炎(UC)的发病率分别为每10万人年23.1、51.2和55.2。
- CD患者发生EoO的风险高于无CD或UC诊断者(IRR 5.4,p<0.01)。
- UC患者发生EoO的风险也高于无CD或UC诊断者(IRR 3.5,p<0.01)。
核心结论
- 基于人群的前瞻性队列分析显示,IBD患者发生EoO的风险显著更高,反之亦然。
- 并发诊断可能改变IBD相关和EoO相关并发症的风险。
- 需要研究以明确这些观察结果背后的机制。
研究设计与样本
- 前瞻性队列分析,使用Truven MarketScan数据库(2009-2016年)估算EoO在克罗恩病(CD)或UC患者中的发病率与患病率,以及IBD在EoO患者中的发病率与患病率。
- 采用Cox比例风险模型和Kaplan-Meier法评估并发诊断患者中EoO相关或IBD相关并发症的风险。
- 共纳入134 013 536名个体。
主要发现
- 在134 013 536名个体中,EoO、CD和UC的发病率分别为每10万人年23.1、51.2和55.2。
- CD患者发生EoO的风险高于无CD或UC诊断者(IRR 5.4,p<0.01;患病率比[PR] 7.8,p<0.01)。
- UC患者发生EoO的风险高于无CD或UC诊断者(IRR 3.5,p<0.01;PR 5.0,p<0.01)。
- EoO患者发生CD的风险高于无EoO或IBD诊断者(IRR 5.7,p<0.01;PR 7.6,p<0.01)。
- EoO患者发生UC的风险高于无EoO或IBD诊断者(IRR 3.4,p<0.01;PR 4.9,p<0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Eosinophilic oesophagitis (EoO) and IBD are immune-mediated diseases of the gastrointestinal tract with possible overlapping pathogenic mechanisms. Our aim was to define the epidemiology and clinical implications of concurrent EoO and IBD diagnoses. DESIGN: We conducted a prospective cohort analysis using the Truven MarketScan database (2009-2016) to estimate the incidence and prevalence of EoO in patients with Crohn's disease (CD) or UC and vice versa. Cox proportional hazards and Kaplan-Meier methods were used to estimate the risk of EoO-related or IBD-related complications among patients with concurrent diagnoses. RESULTS: Among 134 013 536 individuals, the incidence of EoO, CD and UC were 23.1, 51.2 and 55.2 per 100 000 person-years, respectively. The risk of EoO was higher among patients with CD (incidence rate ratio [IRR] 5.4, p<0.01; prevalence ratio (PR) 7.8, p<0.01) or UC (IRR 3.5, p<0.01; PR 5.0, p<0.01), while the risk of IBD was higher among patients with EoO (CD: IRR 5.7, p<0.01; PR 7.6, p<0.01; UC: IRR 3.4, p<0.01; PR 4.9, p<0.01) versus individuals without either diagnosis. Concurrent diagnosis of EoO and IBD was associated with greater composite risk of IBD-related complications (CD: adjusted HR (aHR) 1.09, p=0.01; UC: aHR 1.10, p=0.04) but lower composite risk of EoO-related complications (aHR 0.59; p<0.01). CONCLUSION: Based on a population-based prospective cohort analysis, the risk of EoO is significantly higher among patients with IBD and vice versa. Concurrent diagnoses might modify the risk of IBD-related and EoO-related complications. Studies defining the mechanisms underlying these observations are needed.
引用
- Limketkai BN, Shah SC, Hirano I, et al. Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis. Gut. 2019. PMID: 30923072. doi:10.1136/gutjnl-2018-318074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。